Trial Profile
Multicenter, Open-labeled, Controlled Phase II Study: Trans-catheter Chemo-embolization Combined With rAd-p53 Gene Injection in Treatment of Advanced Hepatocellular Carcinoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Contusugene ladenovec (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Shenzhen SiBiono GeneTech
- 21 Apr 2015 New trial record